Cell Source, Inc. Deferred State and Local Income Tax Expense (Benefit)
Cell Source, Inc. (CLCS) reported Deferred State and Local Income Tax Expense (Benefit) of -$487.50 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-04-07
- Cell Source, Inc. deferred state and local income tax expense (benefit) for fiscal 2024 was -$487.50K.
- Cell Source, Inc. deferred state and local income tax expense (benefit) for fiscal 2023 was -$554.25K.
- Cell Source, Inc. deferred state and local income tax expense (benefit) for fiscal 2022 was -$388.96K.
- Cell Source, Inc. deferred state and local income tax expense (benefit) for fiscal 2021 was -$658.72K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | -$487.50K 10-K · filed 2026-04-07 |
| 2023-12-31 | -$554.25K 10-K · filed 2026-04-07 |
| 2022-12-31 | -$388.96K 10-K · filed 2024-06-24 |
| 2021-12-31 | -$658.72K 10-K · filed 2023-08-08 |
| 2020-12-31 | -$546.64K 10-K · filed 2022-04-15 |
| 2019-12-31 | -$474.63K 10-K · filed 2021-04-15 |
| 2018-12-31 | -$87.41K 10-K · filed 2020-03-30 |
| 2017-12-31 | -$161.00K 10-K · filed 2019-04-01 |
| 2016-12-31 | -$172.00K 10-K · filed 2018-07-25 |
| 2015-12-31 | -$62.00K 10-K · filed 2018-07-25 |
| 2014-12-31 | -$24.00K 10-K · filed 2016-04-14 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-13 |